Denver’s Life Sciences Funding Sees YoY Increase
Cushman & Wakefield has published new insights on Life Sciences Funding. Private capital funding has accelerated growth in the life sciences sector over the last decade. Record flows to the sector helped drive up valuations in preparation for initial public offerings (IPOs), which hit a record in 2020. While the frenzied pace of funding and
Denver’s Life Sciences Funding Sees YoY Increase Read More »











